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The localisation of cellular DNA and RNA sequences in human tissues has greatly facilitated our understanding of disease processes. More than any other technique, in situ hybridisation (ISH) allowed this to be accomplished. However, ISH does not stand alone and must be taken in the context of other developments in cellular and molecular biology that preceded and post-dated its introduction.
Today, the repertoire of in situ hybridisation has been extended to include: DNA in situ hybridisation with double stranded DNA probes, oligo DNA probes and peptide nucleic acid probes (PNAs); RNA in situ hybridisation with riboprobes, oligoprobes and cDNA probes; and the newer techniques of in cell amplification, including DNA polymerase chain reaction ISH (DNA PCR ISH), labelled primer driven DNA in situ amplification (LPD ISA), DNA/PNA PCR ISH, RNA reverse transcription PCR ISH (RT PCR ISH), labelled primer driven in situ RNA amplification (LPD ISRA), and isothermal in situ amplification techniques including in situ isothermal replication (IS 3SR). The marriage of PCR technology and in situ hybridisation now allows single copy mammalian gene detection and extremely sensitive mRNA detection. In this review, we analyse the historical background to in cell amplification, the discovery of non-isotopic ISH (NISH), PCR, and early techniques that were used for DNA and RNA amplification. We will then outline detection sensitivity issues and review the major in cell amplification techniques. Like most new molecular biological systems, there has be an explosion of newly described modifications, many of which we will review. Finally, we will present realistic alternative techniques that give equally sensitive results with in cell PCR amplification and discuss the advantages and disadvantages of each system.
Historical background
In 1955, Arthur Kornberg of Stanford University, USA discovered DNA polymerase, an enzyme normally involved in DNA replication and repair and the essential powerhouse tool of the PCR. 1 When the PCR technique was first introduced, the Klenow fragment of DNA polymerase I from Escherichia coli was used. Recombinant Taq polymerases are now used extensively, and greatly facilitate the use of the PCR process.
Another important milestone for those working with ISH and in cell amplification came in 1975, when Edwin Southern described a technique for the localisation of specific sequences within genomic DNA using electrophoretic transfer techniques. Specific sequences were subsequently detected using oligonucleotide probes (short fragments of single stranded DNA), complementary to the DNA sequences of interest; he called this technique Southern hybridisation. 2 Analogous techniques for RNA and protein analyses are called northern and western hybridisation, respectively.
Initially, radioactively labelled probes ( 32 P, 35 S, 3 H) were used to detect sequences in Southern analysis, but later non-isotopic labels including biotin, digoxigenin, fluorescein, and dinitrophenol (DNP) were used. 3 The technique of in situ hybridisation was first published in 1969. 4 5 For the first time, it allowed direct correlation between hybridisation signals and tissue morphology. Specific applications to cryostat, paraYn wax, chromosomal, and electronmicroscopic preparations were soon reported. [6] [7] [8] [9] The PCR appears to have been described initially by the Russian scientist Khorana in the early 1970s 10 but was named PCR in 1983 by Kary Mullis, who subsequently received the Nobel Prize for Chemistry in 1994 for his work on the PCR.
The story of the development of the PCR is an interesting one and is central to our understanding of how solution phase PCR and in cell amplification works. Initially, the PCR method used the Klenow fragment of E coli DNA polymerase I, which conveniently was found to amplify short DNA fragments. However, its inability to withstand high temperatures during the PCR reaction limited its eVective use as a core enzyme for DNA PCR. Essentially, the PCR consists of three steps: denaturation of the DNA sample at 94°C; annealing of primers (short strands of DNA complementary to the ends of the sequence to be amplified), usually carried out at 45-72°C; and an extension phase, which allows Taq DNA polymerase to add deoxynucleotides to the end of the primers, thus creating a new DNA strand. This process is repeated 20-40 times, depending on the initial starting copy number, the amount of competing DNA sequences, the state of the DNA molecule being amplified, the eYciency of primer design, and the optimisation of the PCR kinetics. Subsequently, with the discovery of thermostable DNA polymerases such as Taq (Thermus aquaticus) polymerase, the PCR process became simpler. These enzymes are active at higher temperatures, thus increasing specificity and the rate of DNA synthesis. 11 12 There are two diVerent targets for nucleic acid amplification. DNA, the nucleic acid information located in the nucleus of each cell is determined by the sequence of nucleotide bases, which are linked in a phosphate backbone of double stranded DNA. The other molecule of interest is RNA, which is the precursor molecule for each protein. RNA is transcribed from DNA, with splicing out of intronic sequences, leaving an mRNA molecule composed of exonic DNA sequences only. Occasionally, some genes, such as CD 44, show evidence of intron splicing and retention, where intronic DNA and RNA sequences are represented in RNA molecules.
The PCR uses essential reagents to bring about amplification of DNA and RNA molecules. For DNA amplification, a primer pair is used, along with deoxynucleotides (dNTPs: dATP, dCTP, dGTP, dCTP, and dUTP), magnesium chloride, potassium chloride, Taq DNA polymerase, Taq DNA buVer, and DNA template. The primer pair is essentially the foundation of the reaction (fig 1) , from which DNA strand specific synthesis occurs. For RNA amplification, the rationale is diVerent. Here, the initial step is to create a complementary DNA (cDNA) template from the RNA in the sample. This is achieved through the use of a reverse transcriptase (present normally in retroviruses). Again, many reverse transcriptases are now commercially available including moloney murine leukaemia virus (MMLV), avian myeloblastosis virus (AMV), superscript I and II, and the intriguing rTth DNA polymerase, which has both reverse transcription and DNA polymerase activity, making RNA amplification a simple one step procedure. The success of the PCR is determined largely by the design of the primers, optimisation of PCR conditions (such as optimising the magnesium chloride concentration for DNA amplification or the manganese acetate concentration for rTth RNA amplification), and the integrity of the DNA and RNA in the sample. In addition, some clinical samples contain Taq polymerase inhibitors, and this phenomenon is not understood clearly. 13 There are now several well described modifications of the basic PCR technique including asymmetric PCR (using a molar excess of one of the PCR primers to make a single stranded PCR product), inverse PCR (which allows the investigator to look at sequences outside the region of interest), competitive PCR (for gene dosage assays), and "Taq Man" PCR (which uses a conventional primer pair in addition to a "Taq Man" probe), for accurate gene quantification studies. Analogous techniques such as ligase chain reaction (LCR) and isothermal replication (3SR) have also been described. These are basic modifications of the PCR, but they use diVerent chemistries. Thus, LCR uses a thermostable ligase, which eVectively joins pieces of DNA strands, and 3SR uses T7 polymerase to create cDNA templates from RNA. 14 15 In cell amplification techniques allow the specific detection of DNA and RNA molecules by amplification of specific target sequences within fixed tissue or cells. 16 For Southern, northern, and solution phase PCR assays, nucleic acid extraction is required first, necessitating the destruction of tissue architecture. ISH and in cell amplification overcome this problem by allowing us to correlate DNA and RNA hybrids/amplified products directly within cells. The ability of in cell amplification to achieve single copy mammalian gene detection is an obvious advantage. The detection sensitivities of standard non-isotopic in situ hybridisation, and tyramide signal amplification (TSA) enhanced ISH are given in table 1. TSA is based on the principle of deposited biotinylated tyramide, catalysing enhanced chromogenic detection ( fig 2) . As can be seen in table 1, most non-complex ISH techniques allow the investigator to detect 5-15 copies of viral target, with single copy mammalian gene detection rarely achieved except when using TSA and complex five step immunocytochemical techniques. Under certain conditions of high stringency, fluorescent in situ hybridisation (FISH) does allow single copy gene detection, but this is very much dependent upon the operator and is not always reliable.
DNA in cell amplification techniques
Direct in cell amplification methods use labelled dNTPs or labelled primers in the PCR mix, giving a directly labelled PCR product within the cell. Indirect methods require an in situ hybridisation step to detect unlabelled product. In general, direct techniques are simpler to perform, but are fraught with diYculties, because non-specific signal generation is a common problem.
IN SITU PCR (DIRECT METHOD)
This refers to DNA amplification using solution phase PCR reagents placed on top of fixed and permeabilised tissue specimens or cells attached to glass slides. The reaction proceeds by incorporating labelled oligonucleotides (such as digoxigenin-11-dUTP, biotin 11dATP, or fluorescein labelled nucleotides) into newly synthesised DNA during amplification. The fixation process preserves cell morphology and proteolytic digestion facilitates access of PCR reagents to their target DNA sequences. Subsequently, the labelled amplicon (PCR product) is detected within the cell by means of standard immunocytochemical protocols, such as a one step detection with an antidigoxigenin antibody conjugated with alkaline phospatase (Boehringer Manheim, Mannheim, Germany). A hybridisation step is not necessary (fig 3) . [19] [20] [21] The disadvantages of this technique will be discussed later and are reviewed by Long et al. 22 23 
In situ amplification
In situ amplification with labelled primers
In situ hybridisation with a labelled probe
Detection Direct detection
Indirect in situ PCR Direct in situ PCR (e.g. labelled primer in situ PCR) This refers to in cell DNA amplification using the PCR. 21 The amplified product is detected by in situ hybridisation using a labelled internal probe, or a double stranded genomic probe. Conventionally, 5' end labelled (such as digoxigenin, biotin, or DNP) oligoprobes are used for ISH reactions. Conveniently, when using genomic probes, nick translated double stranded probes (as used in conventional ISH) can be used. In addition, randomly primed probes can be applied (table 2) .
Figure 4 (A) Primed in situ synthesis (PRINS) and (B) cyclic PRINS, in which a single primer is used to catalyse a single stranded product accumulation. The technique is suitable for metaphase spreads and interphase nuclei.

DNA IMMERSION HISTO PCR
This involves the amplification of whole tissue sections and/or cell preparations attached to glass coverslips in a standard eppendorf PCR tube, with conventional PCR conditions applied. The PCR product is detected using in situ hybridisation, or a labelled primer approach. 24 
PRIMED IN SITU SYNTHESIS (PRINS)
This uses a single primer, which is annealed to chromosomal DNA sequences (interphase nuclei or metaphase spreads), and then amplified in the presence of a labelled modified oligonucleotide (such as digoxigenin 11 dUTP) by Taq DNA polymerase to generate a single stranded PCR amplicon (asymetric PCR) (fig 4) . 25 CYCLIC PRINS (DIRECT METHOD) This is a more sensitive detection system compared with PRINS. This technique uses several cycles of amplification to increase the concentration of amplicon present and thus increase detection sensitivity.
IN CELL "Taq Man" PCR "Taq Man" PCR is an ultrasensitive, quantitative, solution phase PCR method, which enables low copy nucleic acid detection in an endpoint or real time format ( fig 5) . 26 27 "Taq Man" technology is based on the 5'→3' nuclease activity of DNA Taq polymerase, allowing direct detection of the PCR amplicon by release of a fluorescent reporter molecule during the amplification reaction. The probe is usually a 20-30 mer in size, with a fluorescent reporter dye at the 5' end and a rhodamine quencher molecule at the 3' end. When the probe is intact, no fluorescence is seen. After the probe has hybridised with the target sequence (which is always between the two primer sites), the 5'→3'nuclease activity cleaves the reporter molecule during DNA strand polymerisation in each PCR cycle. As a result, fluorescence increases because the reporter is now removed from the influence of the quencher sequence. In addition, the 3' end of the "Taq Man" probe is phosphorylated to prevent extension by Taq DNA polymerase. "Taq Man" PCR technology facilitates the measurement of gene expression and DNA load in cells. The impact of this technology on in situ applications will be enormous because it will be possible to examine and determine the copy number of any gene in any cell and also it will allow us to calculate the sensitivity of in situ amplification techniques.
IN SITU LIGASE CHAIN REACTION (IS LCR)
This is a sister technique to PCR, which uses two sets of primers A,A* and B,B*. 14 A thermostable ligase is used to ligate the primers on opposite strands. Thus, the length of the LCR product is the sum of the lengths of the A and B and A* and B* primers, usually 40-60 mer in size. In addition, the ligase chain reaction can be coupled with PCR, which increases the yield of the amplicon. This procedure is called LDR (ligase detection reaction). The advantage of this technique is that mutation specific LCR primers can be used for the analysis of single point mutations or polymorphisms within the cell.
RNA in cell amplification techniques
To amplify RNA sequences within the cell, we can adopt three basic primer approaches: (1) exonic primers, (2) semi-junctional primers, and (3) junctional primers ( fig 6) . There are several techniques used to amplify RNA.
IN SITU REVERSE TRANSCRIPTION PCR (IS RT PCR) (DIRECT METHOD)
This refers to mRNA amplification in tissue specimens and in cells by initially creating a cDNA template, using a reverse transcriptase enzyme, such as MMLV or AMV. This cDNA is then the target for Taq DNA polymerase catalysed PCR amplification. Alternatively, a simple one step method can be applied using rTth polymerase, which possesses both reverse transcriptase and DNA polymerase activities. Labelled dNTPs can easily be incorporated during the PCR amplification process.
RT TRANSCRIPTION PCR IN SITU HYBRIDISATION (RT PCR ISH) (INDIRECT METHOD)
This refers to mRNA amplification in tissue specimens by first creating a cDNA template and then amplifying this cDNA template, as in IS RT PCR. Subsequently, the in cell amplified product is detected with an internal labelled oligoprobe or PCR generated single or double stranded probe.
LABELLED PRIMER DRIVEN RNA IN CELL AMPLIFICATION (DIRECT METHOD)
This is a special modification of the basic in situ RT PCR technique using labelled primers (such as biotin, digoxigenin, or DNP) for in situ RNA amplification within cells and tissues.
IN SITU 3SR (IS 3SR)
This refers to self-sustained sequence replication and it is a two enzyme isothermal in vitro amplification technique based on multiplying mRNA into cDNA intermediates that contain promoter sequences for RNA transcription. RNA polymerase (T7 or SP6) then produces several copies of RNA, which increases the sensitivity of the reaction. 28 The obvious advantage of this technique for in cell amplification is that it is isothermal (carried out at one temperature), thereby preserving tissue morphology. In addition, dedicated IS PCR equipment is not needed.
How do I perform in cell amplification of DNA?
The technique follows three basic steps 29 
:
x cell/tissue pretreatment x in cell DNA amplification x detection of amplified product (direct or indirect systems) Table 3 lists commonly used fixatives for in cell DNA amplification. Formaldehyde based fixatives cause extensive crosslinking of DNA to DNA, and of DNA to histone proteins and other charged molecules within the nucleus. This has implications for DNA amplification, where DNAhistone protein crosslinks might interfere with Taq DNA polymerase progression during the elongation phase of PCR. 30 After fixation, cells or tissue sections must be permeabilised. The fixed and permeabilised cells function as "amplification sacks" with semi-permeable membranes so that: (1) the PCR reagents can penetrate into the cell to reach the nucleic acid targets, and (2) the PCR amplicon does not leak out of the cell. The amount and time of proteolytic digestion varies from assay to assay, depending on the type of specimen examined. An adequate balance between digestion and permeablisation procedure has to be determined, with the aims of both maintaining cellular morphology and avoiding diVusion of the PCR product out of the cell. Therefore, in all cases, the optimum concentration of protease for particular tissues or cells has to be titrated empirically. The commonly used proteolytic agents include: proteinase K (Boehringer Manheim), pepsin/HCl, proteinase K, and SDS (sodium dodecyl sulphate; Sigma). In addition, acid hydrolysis (0.02-0.2 N HCl) can be used and microwave irradiation can be used to unmask nucleic acid.
Depending on the enzyme system used for immunocytochemical detection (alkaline phosphatase or horseradish peroxidase), it is recommended that endogenous enzyme activity is blocked before amplification and detection to avoid false positive results. Incubation with a solution of 0.1% sodium azide and 0.3% hydrogen peroxide for 15 minutes is sufficient to quench endogenous peroxidase activity in most cells and tissues; alternatively, 20% ice cold acetic acid for 10 seconds quenches endogenous alkaline phoshatase activity. Occasionally, levamisole is needed to quench endogenous alkaline phosphatase activity. 31 
IN CELL AMPLIFICATION
Since the original description of in cell amplification by Haase et al, 32 dedicated equipment has become available to perform in cell DNA amplification. Attaining the correct temperatures for denaturation, annealing, and extension at the individual cell level on the glass slide is crucial for the success of in cell PCR. Previously, we have reported the phenomenon of "thermal lag", encountered when using a standard PCR thermal cycler. 33 The diVerence between the block temperature and that of the cell can be as great as 5°C. The newly designed in cell amplification thermocyclers (IS-PCR 1000; Perkin Elmer Applied Biosystems, Foster City, USA. Hybaid Omnigene/Omnislide; Teddington, UK. MJB in situ thermocycler; Watertown, USA) and microprocessor controlled ovens (fig 7) specifically correct for this, allowing successful in cell amplification.
Haase et al amplified lentiviral DNA segments in single, fixed cells suspended in a PCR buVer (very much like immersion histo PCR) and subsequently cytospun on to microscopic slides. 32 The amplicon was detected by in situ hybridisation. Initially, microscope slides were Figure 7 The IS-PCR system 1000 (Perkin Elmer), which is designed specifically for in cell amplification.
Figure 8 The sealing chamber, consisting of the assembly clip and disc for the IS-PCR 1000 system (Perkin Elmer). This allows compartmentalisation of the PCR solution during slide based PCR assays.
placed in an "aluminium foil boat" on top of the heating block of a standard solution phase PCR machine. To minimise evaporation during the thermocycyling process, the PCR mixture was overlaid with mineral oil and glass coverslips, and sealed with nail polish. 34 Despite these modifications, the PCR reaction was often suboptimal, with reaction failure reported commonly. Newly designed tight sealed, non-evaporating amplification chambers (Perkin Elmer Applied Biosystems) increase amplification eYciency, obviating the need for nail polish or rubber cement (fig 8) .
The PCR reagents required for in cell DNA amplification diVer somewhat from those used in standard DNA solution phase PCR. Table 4 compares the typical reagent set up for a standard solution phase DNA PCR and an in cell DNA PCR. Success of the in cell reaction is dependent upon several variables: the eYciency of pretreatment, the maintenance of tissue/cellular morphology, primer design, and reaction kinetics. To simplify the in cell amplification procedure, a two step PCR protocol has been adopted by many investigators, resulting in a combined annealing/extension step. Denaturation times and annealing/ extension times are also increased to facilitate Taq DNA polymerase accessibility to its target sequence in the setting of a volume limited nucleus. The "hot start" PCR modification (preheating the PCR solution and the slide to 70°C) is also used, and minimises primer dimerisation and mispriming events.
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If one uses in situ ligase chain reaction (IS LCR), the concentration of thermostable ligase used is two to three times that of a standard solution phase LCR. Primers (four in number) are also increased in concentration, with similar increases in other reagent concentrations as is needed for in cell PCR (table 4) .
DETECTION OF THE AMPLIFIED PRODUCT
Depending on whether direct or indirect techniques have been used, the amplified product is either labelled or unlabelled. Standard immunocytochemical detection techniques are used as for in situ hybridisation and have been described previously. 19 31 The numbers of immunocytochemical steps largely depend on the sensitivity required, keeping in mind what can be achieved using standard NISH and the specific detection protocol (table 1) . For indirect techniques, an in situ hybridisation step is performed using an oligoprobe or genomic probe. Maximum specificity is achieved using an internal oligoprobe, whereas genomic DNA probes will hybridise with the amplicon, the primers, and other sequences outside the amplified region. Other strategies can be adopted to increase the specificity of the hybridisation reaction, including concatameric probes (probes with overlapping ends) or tandemly repeated internal probes (three to six for each amplicon). In addition, the numbers of reporter molecules attached to a probe can vary enormously, depending on the type of labelling reaction used.
Conventionally, when using 5' and 3' end labelling, only one reporter molecule is attached to each probe. Thus, for each hybridisation event, only one reporter can be seen. 3' tailing (using the Genius 3' tailing kit; Boehringer Mannheim, Indianapolis, USA) adds between five and 10 reporter molecules for each probe. This increases the signal, but at the expense of increased background. One must choose the system that gives the optimal signal to noise ratio for the particular application. The stringency of the hybridisation must also be established correctly. Typically, medium stringency conditions should be used first. 21 A typical hybridisation solution for oligoprobes would be: 2× saline sodium citrate (SSC), 10% formamide, and 5-10% dextran sulphate. For genomic probes, the concentration of formamide could be increased to 50%. Typically, hybridisation temperatures are 37°C, but higher temperatures can be used, which of course increases the stringency. Typically, hybridisation can be carried out at T m −10°C to −20°C, where T m is defined as the theoretical solution temperature at which half of the probe is annealed to its complementary strand and half is not annealed. This value is solution dependent, being subject to the ionic strength of the solution, and it diVers in tissue sections.
Here it is called the T m t, a value calculated as a midpoint temperature between the temperature at which one can see a hyridisation signal retained on the tissue section and the temperature at which it disappears when altering posthybridisation washing conditions. 42 The stringency of the post-hybridisation wash can also be adjusted by decreasing the salt concentration of the washing solution, from 2× SSC to 0.1× SSC, and increasing the temperature. In addition, formamide can be added, but we feel that this complicates many assays and adds another variable to the establishment of the correct washing stringency.
The other diYculty to be overcome is retention of the amplicon. This is a delicate balancing procedure. It is achieved largely by correct pretreatment, amplifying to a level that is just detectable, and creating a PCR product that is big enough to remain within the cell. There have been many attempts to prevent diVusion or back diVusion from target positive cells to negative bystander cells. One strategy uses concatameric primers (that is, overlapping primers), which creates a large PCR product. 19 Another approach is to use a bulking agent, such as biotin 11dUTP (Sigma), incorporated into the PCR product during the PCR and then detected with a digoxigenin labelled oligoprobe. Another strategy is to allow a second in cell PCR to proceed in parallel with the first (using a reference gene such as actin) to increase the density of the intranuclear space, making it less likely for product diffusion to occur, because of volume limitation. We suggest that running a parallel asymmetric PCR (with the accumulation of a single stranded product) can prevent back diVusion, because much of the phenomenon is caused by single stranded forms of the target sequence adhering to cytoplasmic membrane sticky sites in neighbouring cells (J J O'Leary et al, unpublished data).
To prevent loss of the product, we advise a post-amplification fixation step with 100% ethanol or 2% paraformaldehyde. If product diVusion is a major problem, we suggest that investigators decrease the numbers of rounds of amplification (perform only 10-15 rounds, instead of the typical 30-40 rounds). The numbers of rounds of amplification needed is determined largely by the numbers of copies of the target sequence for each cell and how well these copy numbers are preserved during the fixation process.
The importance of adequate and appropriate controls for each PCR experiment cannot be over emphasised because there are many, undesired pitfalls. Table 5 lists the minimum controls Alternatively, a one step reaction using rTth DNA polymerase and a bicine buVer system (Perkin Elmer Applied Biosystems) can be used to carry out in cell RNA amplification more eYciently. This enzyme possesses reverse transcriptase and DNA polymerase activities. Amplification of RNA with this system has some advantages, primarily that reverse transcription with rTth polymerase can be carried out at higher temperatures (up to 60°C) compared with AMV or MMLV (42°C), thereby reducing RNA secondary structure and facilitating cDNA synthesis. In addition, the use of a single bicine buVer system greatly facilitates the performance of in cell RNA amplification, obviating the need to change buVer systems during amplification or to use chelating agents. Table 6 illustrates the diVerence between a typical solution phase RNA PCR and an in cell RNA assay.
To prevent amplification of genomic DNA, a DNase digestion step should be carried out before in situ amplification takes place. However, it is often diYcult to achieve full DNase digestion when using paraYn wax embedded tissue and thus newer strategies can be applied. Moreover, incomplete DNase digestion leads to undesired "DNA repair mechanism" artifacts generated by the exonuclease activity of the DNA Taq polymerase, particularly if a two enzyme RNA amplification system is used. By using specially designed primers for cDNA amplification ("junctional primers") ( fig 6) , which overspan splice junction sites, only RNA molecules will be amplified. Because RNA is extremely labile in tissues and cells, and because of the eVfect of the pretreatment process, endogenous RNases can easily degrade RNA. Therefore, it is recommended that only solutions and tools that have been treated with diethylpyrocarbonate (DEPC) at a final concentration of 0.1% should be used.
What problems are associated with performing in cell amplification?
In the final analysis, critical review of the results is needed, with careful assessment of the control slides and familiarity with the problems and their solution. Table 7 illustrates some of the common problems and the possible ways of troubleshooting them.
False positive results for direct in cell amplification can be caused by non-specific incorporation of labelled nucleotides (such as digoxigenin-11-dUTP) into damaged DNA. Fragmented or nicked DNA strands undergo a "DNA repair mechanism" catalysed by the exonuclease activity of Taq DNA polymerase. The newly repaired DNA strand will have incorporated the labelled nucleotide, giving a labelled PCR product, which is non-target dependent and occurs independently of the primer pairs used. This reaction even occurs at room temperature. Thus, IS PCR with labelled nucleotides should not be used when performing DNA in cell amplification (fig 9) . 10) . [43] [44] [45] [46] PNA is an uncharged molecule. While in situ hybridisation procedures with DNA or RNA probes are very time consuming, non-charged PNA probes reduce the hybridisation process dramatically. Typically, hybridisation times can be reduced to 5-10 minutes as compared with three to four hours for DNA oligoprobes and 24 hours for genomic probes. Hybridisation conditions are also easier to establish because it appears that a wide range of hybridisation buVers work for most PNA probes (J J O'Leary et al 1998, unpublished data). Furthermore, PNA in situ hybridisation aVords greater flexibility when establishing hybridisation stringency conditions. A mismatch in a DNA/PNA duplex lowers the T m by on average 15°C, in contrast to 5-10°C for a DNA/DNA duplex, making it possible to introduce this methodology for the screening of single base pair mutations and for allele specific detection. Because of the high specificity and higher T m of PNA/PNA duplexes compared with DNA/DNA complexes, it is possible to use PNA probe technology for the detection of short DNA or RNA sequences in cells and chromosome spreads (such as, telomeric repeats). In combination with PCR ISH, this new technique greatly simplifies the in situ hybridisation component of the reaction. However, the cost of PNA oligomers still limits their use in standard ISH applications. The combination of PNA and TSA technology is obviously attractive and will oVer detection as sensitive as most in cell PCR/LCR reactions.
Conclusion
As we have seen, there is a now a wide repertoire of in cell amplification techniques for the detection of low copy viral, protozoal, and mammalian DNA and RNA sequences in tissue sections and cells (table 8; figs 11 and  12 ). The choice of reaction is totally dependent on the particular target being amplified and the skill and experience of the operator. These techniques are now robust and with newer chemistries and novel methodologies (such as IS-"Taq Man" PCR) becoming available many more targets can be examined.
In many ways, the world of in cell amplification mirrors the early days of immunocytochemistry and in situ hybridisation: "greeted by enthusiasm, scorned by failure and established by the dedicated"!!!
